素作为心力衰竭的预后生物标志物:综合性综述
Machineni Sravani1, Manickam Kokila1, Kasinathan Ramanathan1
1Vinayaka Mission's Medical Colege & Hospital, Pondicherry, India.
Folia medica
|December 30, 2025
概括
反映血管压素活性的生物标志物可佩 (Copeptin) 在预测心力衰竭 (HF) 结果方面显示出前景. 升高的水平表明死亡率和住院率较高,有助于风险分层超出传统标志物如BNP.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 临床风险分层的临床风险分层
背景情况:
- 心力衰竭 (HF) 是一个重大的全球健康挑战,患病率高,预后不佳.
- 目前的生物标志物,如B型尿酸 (BNP,NT-proBNP) 对于HF诊断和风险评估至关重要,但局限性需要额外的预后工具.
- 平素是血管压素系统活性的标记物,已成为HF管理中的潜在预后指标.
研究的目的:
- 审查可佩的生理作用及其在多种心力衰竭表型中的预后价值.
- 探索可佩在临床风险模型中的整合,以提高心力衰竭预后.
- 讨论在心力衰竭管理中采用可佩的临床应用的挑战和未来方向.
主要方法:
- 文献综述综合了佩在心力衰竭中的生理基础和临床实用性的证据.
- 分析了与死亡率,住院病例和急性和慢性HF疾病进展相关的科佩水平的研究.
- 检查平素在多标志物策略中的作用以及指导心力衰竭治疗的潜力.
主要成果:
- 在心力衰竭患者中,高水平的可佩始终与增加的死亡率,住院和疾病进展有关.
- 科佩可提供早期检测血液动力学压力,补充传统生物标志物如BNP和NT-proBNP.
- 证据支持可佩在识别高风险HF患者,指导治疗决策和监测疾病轨迹方面的实用性.
结论:
- 平素是心力衰竭中一个有价值的预后生物标志物,提供超出已建立标志物的增量预测价值.
- 临床采用挑战包括测试标准化,成本效益和定义普遍接受的切断值.
- 未来的研究将重点放在可佩导疗法,人工智能驱动的模型和精密医学上,这些研究可能会优化心力衰竭的管理.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
493
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.8K
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511
01:29Heart Failure II: Pathophysiology
658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
01:30Heart Failure IV: Classification and Diagnostic Evaluation
281
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
281
01:17Pathophysiology of Heart Failure
2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
01:30Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195
01:26Heart Failure III: Clinical Manifestations
430
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
430